Skip to main content
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 2000 Nov;131(6):1097–1104. doi: 10.1038/sj.bjp.0703678

Effects of acidosis and NO on nicorandil-activated KATP channels in guinea-pig ventricular myocytes

Gustavo A Moncada 1,2, Yukio Kishi 1, Fujio Numano 1, Masayasu Hiraoka 3, Tohru Sawanobori 2,*
PMCID: PMC1572434  PMID: 11082116

Abstract

  1. Nicorandil is a hybrid compound of K+ channel opener and nitrate. We investigated a possible interaction of acidosis and nitric oxide (NO)-donors on the nicorandil-activated ATP-sensitive K+ channel (KATP) in guinea-pig ventricular myocytes using the patch-clamp technique.

  2. In whole-cell recordings, external application of 300 μM nicorandil activated KATP in the presence of 2 mM intracellular ATP concentration ([ATP]i) at external pH (pHo) 7.4, but the activated current was decreased by reducing pHo to 6.5–6.0.

  3. Single-channel recordings of inside-out patches revealed decreased open-state probability (Po) of KATP activated by nicorandil with reducing internal pH (pHi) from 7.2 to 6.0, whilst the channel activity increased at low pHi in the absence of nicorandil.

  4. Application of NO donors, 1 mM-sodium nitroprusside (SNP) or -NOR-3 to the membrane cytoplasmic side at pHi 7.2 increased the channel activity but decreased it at pHi 6.5–6.0. Neither removal of the drugs nor application of NO-scavengers reversed depression of channel activity induced by NO-donors.

  5. We conclude that an increase in pHo and pHi depresses rather than stimulates the nicorandil-activated KATP. Since NO-donors at low pHi exhibited a similar trend, involvement of H+ and NO interaction can be considered as a mechanism of decreased KATP activated by nicorandil.

Keywords: Nicorandil, K+ channel opener, nitrates, NO-donors, patch-clamp

Introduction

Nicorandil is a potassium channel opener that targets the ATP-sensitive potassium channel (KATP) (Hiraoka & Fan, 1989; Nakayama et al., 1991; Takano & Noma, 1990). Based on its chemical structure nicorandil can be considered as a hybrid compound having nitrate and K+ channel opening properties (Taira, 1987). The drug is clinically available by virtue of its ability to dilate the coronary vessels and increase the coronary flow reserve in patients with chronic ischaemic heart disease (Frampton et al., 1992; Goldschimidt et al., 1996; Krumenacker & Roland, 1992). Recently much attention has been paid to its effects mimicking ischaemic preconditioning (Matsubara et al., 2000; Patel et al., 1999). Whilst the potency for nicorandil to activate KATP is not strong compared to other agents, the drug has a unique action requiring the presence of MgADP for the channel activation (Shen et al., 1991), whilst other studies demonstrated the channel activation by nicorandil in the absence of ADP at the single channel level (Takano & Noma, 1990). It has been further suggested that nicorandil could activate KATP in the absence of ADP in external acidotic condition suggesting more effective action at low pHo than at normal pHo (Jahangir et al., 1994). Other studies indicated that KATP activated by another KCO, pinacidil, was suppressed at low pHo and increased at high pHo, suggesting an external site of interaction for the channel and H+ (Kwok & Kass, 1994).

During myocardial ischaemia important changes in external and internal pH as well as changes in the ratio of intracellular ATP and ADP concentrations take place (Allen et al., 1985). The modulation of KATP has been studied to demonstrate that moderate increase in H+ concentrations, acidosis, itself has the ability to increase the activity of KATP (Cuevas et al., 1991; Davies, 1990; Fan & Makielski, 1993; Koyano et al., 1993). Therefore, nicorandil may exert its K+ channel opening potency more strongly during ischaemia or acidotic conditions than in normoxic state and normal pH. However, it is not known how the other aspect of nicorandil as nitrate interacts with the KATP activation. The present study was undertaken to examine a possible interaction between low pH and NO on the nicorandil-activated KATP activity.

Methods

The investigation was conducted in accordance to the guidelines for the care and use of laboratory animals at Tokyo Medical and Dental University.

Cell isolation

Single ventricular myocytes were isolated enzymatically from the ventricles of female guinea-pigs weighing 250–350 g. The technique for cell isolation used in our laboratory has been described previously (Hirano & Hiraoka, 1988). In brief, guinea-pigs were anaesthetized with Na-pentobarbital (30 mg Kg−1, IP) and right after injected intravenously with heparin (300 units Kg−1). The chest was opened under artificial respiration (Respirator Model 141, NEMI Corp, Medwey, MA, U.S.A.) and the aorta was canulated to perfuse retrogradely with the Tyrode solution before the heart was dissected out. After 6 min of perfusion on the Langendorff apparatus, the heart was perfused with a nominally Ca2+ free Tyrode solution for an additional 6 min. The perfusate was switched to Ca2+ free Tyrode solution containing collagenase (5 mg 50 ml−1, Yakult, Tokyo, Japan). After 5–6 min perfusion, the heart was washed out with a high K+, low Cl solution. The temperature of the perfusates was maintained at 35–36°C. The isolated cells were obtained through a mesh (size 200 μM). Rod-shaped cells with clear margin and striation were used for the experiments.

Solutions

In the whole-cell configuration the bath solution was Tyrode solution, and its composition was (mM): NaCl 144, NaH2PO4 0.33, KCl 4.0, CaCl2 1.8, MgCl2 0.53, glucose 5.5, and HEPES 5.0; the pH was adjusted to 7.3–7.4 by addition of NaOH. The Ca2+-free Tyrode solution was prepared by omitting CaCl2 from the Tyrode solution. High K+ low Cl solution contained (mM): KOH 80, glutamic acid 70, taurin 15, KH2PO4 10, HEPES 5, MgCl2 0.5, glucose 11, and K2-ethyleneglycol-O-O′-bis(B-aminoethyl)-N,N,N′,N′-tetraacetic acid (EGTA) 0.5 (pH 7.4-KOH). The composition of the pipette solution was (mM): KCl 120, K2ATP (Sigma Chemical Co., St. Louis, MO, U.S.A.) 2.0, HEPES 5.0 and K4BAPTA (Dojin Co., Kumamoto, Japan) 5.0; the pH was adjusted to 7.2 with KOH. The final K+ concentration was kept constant at 150 mM.

In the case of single-channel recordings (inside-out patch configuration), the bath solution (intracellular medium) contained (mM): KCl 140, glucose 5.5, EGTA 2 and HEPES (or PIPES) 5; the pH was adjusted to 7.3 with KOH. When experiments were conducted in acidotic conditions, bath solutions having different pH values (7.2, 6.5 or 6.0) were adjusted with HEPES or PIPES buffer systems, accordingly. Final pH adjustment was done with 0.1 N HCl. When nucleotides were present in the bath, MgCl2 0.6–0.8 mM was added to the bath. The drugs were dissolved in the bath solution at the concentration indicated in the text. The pipette solution (extracellular medium) contained (mM): KCl 140, CaCl2 1.8, MgCl2 0.53, glucose 5.5 and HEPES 5; the pH was adjusted to 7.3 by adding KOH.

Electrophysiological measurements

Whole-cell current recordings

Membrane currents were recorded using the patch-clamp technique of whole cell configuration (Hamill et al., 1981), using a patch-clamp amplifier (Axopatch ID, Axon Instrument, Foster City, CA, U.S.A.). Glass patch electrodes were made from borosilicate capillary tubes with an outer diameter of 1.5 mm (Clark Electromedical Instruments, Pangbourne, England) using a microelectrode puller (Model PP-830, Narishige Co. Tokyo, Japan) and were heat-polished by a microforge (Model MF-830, Narishige Co., Tokyo, Japan). The electrode resistance was 2–4 MΩ when the pipettes were filled with an internal solution. The recording technique and the data acquisition systems have been described in previous reports (Hirano & Hiraoka, 1988). When the ramp voltage-clamp method was employed, an intelligent arbitrary function synthesizer (model 1731, NF Instruments, Yokohama, Japan) was used to supply the command pulse.

The temperature of the bath chamber was maintained at 34–35°C with a heating system (DTC-100TA, Dia Medical System, Tokyo, Japan). Before establishing contact between the electrode and the cell membrane, the junction potential was adjusted to zero at the level of the bath solution. At the end of each experiment the junction potential was verified again and, adjusted if a difference of more than ±2 mV existed between the first and second measurements. A time-interval of 2–3 min for sequential recording at different pH was established.

Single-channel recordings

Single-channel current recordings were carried-out at room temperature with conventional inside-out patch configuration (Hamill et al., 1981) using the same patch-clamp amplifier as in the whole-cell experiments. The current signals were recorded and stored simultaneously on a videocassette recorder (HR-S7700, Victor, Tokyo, Japan) and a thermal recorder (Omnicorder 8M14-3, NEC-Sanei Instruments, Ltd., Tokyo, Japan) through a PCM data recorder system (RP-882, NF Instruments, Yokohama, Japan) at a conversion rate of 40 kHz. Recorded signals were filtered off-line through a programmable eight-pole Bessel low-pass filter (48 dB/octave, 3625, NF Instruments, Yokohama, Japan) and digitized at a sampling frequency of 10 kHz and stored into a MO disk of a computer (Physio PC-01; Physio-tech, Tokyo, Japan) using an analogue-to-digital converter (Digidata 1200 Interface, Axon Instruments, Foster City, CA, U.S.A.) for later analysis. pCLAMP software (version 6.0.4, Axon Instruments) was used to generate voltage pulse protocols, data acquisition and analysis.

Single channel data analysis

Single channel records were analysed by pCLAMP 6.0 software program on a computer (Physio PC-01; Physio-tech, Tokyo, Japan). The unitary current amplitude of KATP was measured from the all point histograms through Gaussian fitting, or by selecting well-defined long opening and close transitions and measuring the magnitude of the corresponding current steps with horizontal cursors.

Mean patch current (I) was obtained over 30 s as a time averaged currents of KATP, measured as the difference between the baseline (a current level where all channels are in a close state) and the current level where the channels were in the open state with a half height criteria. Data points over the signals were delimited by cursors. The number of active channels in the patch (N), while initially perfusing nucleotide-free solution was regarded as the maximum open state of activity for later comparisons to assess the effect of nucleotides and/or drugs upon the active channels in the membrane-patch. Since the unitary current (i) changes at different pH levels, the I/i quotient was used as a proportional indicator of channel activity. Since KATP could be subject to run-down phenomenon, during each experiment, maximum channel activity was always verified regularly and measurements and calculations were corrected accordingly assuming a linear decrease in the number of active channels.

Drugs

All drugs were freshly prepared before every experiment and diluted into the test solution to obtain the final concentration as indicated in the text. Nicorandil (2-nicotinamidoethyl nitrate; a gift from Chugai Pharmaceutical Co., Tokyo, Japan) was diluted into the test solution. Glibenclamide (a gift from Hoescht Japan, Tokyo) was dissolved in 2% dimethyl sulphoxide (DMSO) and diluted into the test solution. The final concentration of DMSO contained in the test solution was less than 0.01%. We used two NO-donors: Sodium nitroprusside (SNP, Sigma Chemical Co. St. Louis MO, U.S.A.) and (±)-(E)-ethyl-2-[(E)-hydroxyimino]-5-nitro-3-hexeneamide (NOR-3, a gift from Fujisawa Pharmaceutical Co. Ltd. Osaka, Japan). They were directly dissolved into the perfusing solution at the concentration indicated in the text. Exposure to light and oxygen was minimized. NO-scavengers: 5–10 μM oxyhaemoglobin (HbO2, Calzyme Laboratories, Inc. CA, U.S.A.) and 2–3 mM C14H16N2NaO4 (Carboxy-PTIO; Dojindo Kumamoto, Japan) were both directly dissolved into the perfusate to a final concentration as indicated in the text.

Statistical analysis

Data are expressed as mean±s.d. The significance for pH-effect as the only changing factor when comparing more than two groups was assessed by analysis of variances (ANOVA). Comparisons between two groups of data were evaluated by paired or unpaired student t-test, accordingly. A value of P<0.05 was considered significant.

Results

Reduction of external pH affects nicorandil-activated KATP current

Application of 300 μM nicorandil activated outward current at potentials positive to ∼60 mV elicited by a ramp voltage clamp at pHo 7.4. The nicorandil-activated current was completely inhibited by 1 μM glibenclamide confirming the current as KATP (n=4; not shown). When pHo was lowered from 7.4 to 6.8–6.0 in the presence of 2 mM [ATP]i, the nicorandil-activated KATP current was somewhat decreased at pHo 6.8 and further suppression was noted at pHo 6.0 (Figure 1a). Figure 1b presents a summary of the results obtained from 10 different myocytes. The current at 0 mV in the control was 1.22±0.6 nA and it was increased to 3.96±1.97 nA in the presence of 300 μM nicorandil at pHo 7.4 (P<0.01). The nicorandil-activated current was decreased to 1.96±0.95 nA at pHo 6.8 in the presence of the drug (P<0.05 versus nicorandil at pHo 7.4) and further decrease of the current was noted at pHo 6.0 (1.06±0.68 nA; P<0.01 versus nicorandil at pHo 7.4). As we could not detect any increase in the nicorandil-activated KATP current by the whole-cell configuration, we proceeded to examine the modulatory action of pHi on the single KATP currents with inside-out patch configuration.

Figure 1.

Figure 1

Suppression of nicorandil-activated whole-cell current by lowering pHo. (a) Superimposed traces of background I-V curves obtained from a typical case in a single myocyte, at 3 min intervals. ○: Control at pHo 7.4. •: S6.8Addition of 300 μM nicorandil to the bath at pHo 7.4 (Nicorandil, pHo 7.4). ▴: Reducing pHo to 6.8 in the presence of nicorandil (Nicorandil, pHo 6.8). ▪: Further reduction of pHo to 6.0 in the presence of nicorandil (Nicorandil, pHo 6.0). (b) Summarized data from 10 myocytes revealed a significant decrease of the nicorandil-activated K+ current by reducing pHo from 7.2 to 6.8 and 6.0. Each symbol corresponds to the value obtained from individual preparations.

Increased KATP activity by internal acidosis

First, we tested the low pHi-induced modulation of the KATP activity in the absence of nicorandil under our experimental conditions, since reducing pHi from ∼7.4 to 6.5–6.0 was shown to increase the channel activity (Cuevas et al., 1991; Davies, 1990; Fan & Makielski, 1993; Koyano et al., 1993; Vivaudou & Forestier, 1995). Figure 2a presents the effect of lowering pHi on KATP current. When the internal face of the patch-membrane was exposed to the ATP-free solution at pH 7.2 many channels were kept in the open state, and the channels were quickly and largely inhibited by addition of 0.35 mM ATPi. The open-state probability (Po) of the channels was 89±10% in the ATP-free solution and it was 7±5% at 0.35 mM [ATP]i (P<0.01). A significant increase of channel activity became apparent by decreasing pHi from 7.2 to 6.0 (Po; 7±5% versus 32±13%, respectively, n=9; P<0.01) in the presence of Mg2+ as previously reported. Run-down was excluded by observing near complete recovery of the initial Po upon removal of ATP from the internal solution (Figure 2b). As reported previously reduction of pHi slightly decreased the unit amplitude of single-channel current (i) (data not shown).

Figure 2.

Figure 2

Increased KATP activity by lowering pH at the cytoplasmic side of the membrane (pHi). (a) Single-channel record obtained with inside-out patch configuration. The membrane potential was held at −40 mV, while having a 140 mM symmetrical K+ concentrations at both sides of the membrane. Control KATP current was recorded in the absence of nucleotides at pH 7.2 in the bath (pHi). The control current was of large amplitude and off-scaled. Addition of nucleotides, 0.35 mM [Mg.ATP]i+0.12 mM [K.ADP]i whilst keeping the same pHi markedly suppressed the current. Mg2+ was also present at a 0.6–0.8 mM concentration. Whilst lowering pHi to 6.5 at this [ATP]i did not exhibit any change in channel activity, further reduction of pHi to 6.0 increased significantly the Po of the channels. Application of 4.0-μM glibenclamide suppressed the current. C represents the closed level of the channel. Downward deflection indicates inward currents in this and the following figures except Figure 3b. (b) The bar graph showing summarized data obtained from nine different patches under the same experimental condition as in (a).

Effect of acidosis on the nicorandil-activated KATP current

Application of 1 mM nicorandil to the internal solution in the presence of 0.25 mM ATP, 0.1 mM ADP and Mg2+ at pHi 7.2, KATP was activated as similar as the removal of ATP. The nicorandil-activated KATP currents were decreased with reduction of pHi to 6.5 and 6.0 (Figure 3a). Return of pHi to 7.2 or removal of [ATP]i restored the channel activity. Figure 3b represents the amplitude histograms of the records shown in Figure 3a. Reduction of pHi decreased the channel activity. Figure 4 demonstrates the summary data from 10 similar experiments as shown in Figure 3. Po of nicorandil-activated KATP at pHi 7.2 was 84±16%. Decreasing pHi from 7.2 to 6.5 and 6.0, resulted in a significant reduction of KATP activity (Po; 57±20% at pHi 6.5; P<0.01 and 38±12% at pHi 6.0; P<0.01 when compared to pHi 7.2, respectively). Upon return to pHi 7.2, an almost complete recovery to the initial level of channel activity was restored (Po=80±5%).

Figure 3.

Figure 3

Effects of low pHi on nicorandil-activated KATP current. (a) Single channel current record with holding potential at −40 mV. The bath contained 0.25 mM Mg.ATP, 0.12 mM K.ADP, 0.8 mM Mg2+ and 1.0 mM nicorandil. Lowering pHi from 7.2 to 6.5 and 6.0 in the presence of nicorandil reduced the nicorandil-activated KATP current. These effects were reversible upon return of pHi to 7.2. (b) Current histograms of 30 s-analysed segments taken from (a). The letters in brackets indicate the corresponding segment in (a).

Figure 4.

Figure 4

Summarized data for effects of low pHi on nicorandil-activated KATP current. The bar graphs summarize data from 10 different patches. Reducing pHi to 6.5 and 6.0 significantly decreased the channels-activity induced by 1.0 mM nicorandil compared at pHi 7.2. Upon washout of nicorandil and returning to ATP- and ADP-free pHi 7.2 solution, near complete recovery of the initial activity was achieved in all patches excluding the rundown of the channel. Experimental conditions same as those in Figure 3.

Effects of Nitric Oxide on KATP

Since nicorandil is a hybrid compound including NO in its chemical structure, we investigated a possibility that the reduced activity of the nicorandil-activated KATP at low pHi might be caused by an interaction between H+ and NO. For this purpose, we examined effects of NO donors on KATP. We used two different NO-donors: SNP and NOR-3 (see Methods). Figure 5a shows the effect of 1 mM SNP in the presence of 0.25 mM [ATP]i at pHi 7.2. KATP activity increased significantly in the presence of the NO-donor. Figure 5b summarizes data from 11 patches. Po was 17±11% in the absence versus 32±12% in the presence of SNP 5 minutes (P<0.05). Upon removal of the NO-donor, an increase in KATP current was kept ongoing to reach Po values up to 73±38% following 10 min of washout (P<0.05). On the contrary, lowering pHi from 7.2 to 6.0 at constant ATP and SNP concentration caused a significant reduction in KATP activity (Po; 54±34% at pHi 7.2 versus 27±19% at pHi 6.0; P<0.01; n=11) (Figure 6a,b). Using NOR-3, a different NO donor, we observed similar tendency as with SNP. In the presence of 0.25 mM [ATP]i at pHi 6.0, the Po was 28±15% in the absence, whilst in the presence of 1 mM NOR-3, Po decreased to 8±6% (P<0.05; n=5). Washout of the drug did not reverse the current depression, similarly as with the application of SNP. On the other hand, we also observed that a switch in pHi from 6.0–7.2 increased the activity of the channel (Po; 20±16% at pHi 6.0 versus 46±19% at pHi 7.2; P<0.05; n=4) (Figure 6a). Contrary to what we observed at pHi 7.2, removal of NO-donor at pHi 6.0 did not get complete recovery of the channel activity to the previous level. This was not due to run-down of channel activity since the nucleotide-free solution at pHi 7.2 restored complete recovery of the channel activity to the initial level.

Figure 5.

Figure 5

Increased KATP activity at normal pHi induced by NO-donor. (a) Single channel current record obtained from a typical patch. Application of nucleotides and NO-donor, 1.0 mM SNP in the bath is indicated at the top, pHi was kept constant at 7.2 throughout these experiments. In the absence of nucleotides a large current was observed and off-scaled in the record. Decreased channel activity upon addition of 0.25 mM Mg.ATP and 0.12 mM K.ADP was gradually increased by adding 1.0 mM SNP into the bath and continued after the removal of the NO-donor. Increasing [Mg.ATP]i to 0.5 mM caused a similar Po as the level observed at 0.25 mM [Mg.ATP]i before the exposure to SNP, suggesting a reduction to the inhibitory effect of ATP. (b) The bar graphs of data from 11 patches. The channel activity expressed by Po increased significantly by addition of SNP in the presence of nucleotides and washout of the drug increased Po.

Figure 6.

Figure 6

Effects of SNP on KATP at low pHi (a) Experimental conditions of pHi, presence of nucleotides and SNP are indicated on the top. The channel activity at pHi 6.0 in the presence of nucleotides was significantly reduced by the presence of 1.0 mM SNP and return of pHi to 7.2 resulted in increase of channel Po. (b) The bar graphs of summarized data from 11 patches. The pHi at 6.0 and nucleotides concentrations were kept constant with 0.25 mM [Mg.ATP]i, and 0.12 mM [K.ADP]i throughout the experimental conditions. In all patches run-down was excluded by observing nearly complete recovery of activity when perfusing nucleotide-free, pH 7.2 solution after these treatments.

Effects of NO-donors and NO-scavengers on KATP

In the presence of NO-donors at low pHi, we attempted to reverse their depressing effects on KATP by adding NO scavengers, either HbO2 or carboxy-PTIO. However, 5–10 μM HbO2 enhanced rather than reversed the depressing effects of NO donors (Figure 7). Po was 60±5% in the presence of 1 mM NOR-3 alone versus 20±2% in the presence of HbO2 (P<0.01; n=4). At low pHi neither washout of HbO2 nor removal of the NO donor altered the decreased Po of the channels, but an increase of the pHi to 7.2 could increase Po. Run-down was excluded by observing complete recovery of channel activity upon removal of nucleotides at pHi 7.2. Either at normal or low pHi, the compound itself at concentrations ranging 5–10 μM showed a direct suppressing effect on the channel activity. This effect was more prominent at low pHi revealing an additive action to that of the NO-donor. In two additional patches we tested the effect of HbO2 on the nicorandil-activated KATP at normal pHi and again we observed a clear reduction of activity, with its reversal upon washout of HbO2. No significant changes in channel activity were observed by using carboxy-PTIO with a ratio 2 : 1 or 3 : 1 respect to the NO donor.

Figure 7.

Figure 7

Effects of NO scavenger, HbO2 on KATP activity in the presence of NO-donor, NOR-3. Single channel records show that lowering pHi from 7.2 to 6.0 in the presence of nucleotides and Mg2+ increased KATP activity. Increased channel activity was somewhat depressed by addition of 1.0 mM NOR-3 and further decrease was noted in the presence of 5 μM of HbO2. Neither removal of HbO2 nor NOR-3 reversed the depressed activity of the channel, but a change in pHi from 6.0–7.2 increased the Po of KATP. Upon removal of the nucleotides complete recovery of the initial activity took place ruling out the presence of run-down.

Discussion

In the present study we examined two major issues: first, how an increase in external and internal H+ concentrations modulates the activity of nicorandil-activated KATP in guinea-pig ventricular myocytes. Second, the possibility that the modulation caused by acidosis in nicorandil-activated KATP may be related to H+ and NO interaction.

Effect of external pH on nicorandil-activated KATP current

Previous study demonstrated that lowering pHo could enhance the ability for nicorandil to activate whole-cell KATP current in guinea-pig ventricular myocytes (Jahangir et al., 1994). The authors considered that the enhanced action of nicorandil during acidosis was not related to a different ionization state of the drug nor a change in the ATP/ADP ratio, but a direct effect of H+ modulating the interaction between the channel and the drug. Effectiveness of another KCO, pinacidil decreased at low pHo and increased at high pHo (Kwok & Kass, 1994). The findings were interpreted as H+ might modulate the binding site for pinacidil located at the extracellular side of the membrane. Thus, the interaction between H+ and the different types of KCO might be different depending on their chemical structures.

We tested a slightly different view from that of Jahangir et al. (1994) as to the nicorandil action on KATP. That is how the nicorandil-activated KATP could be modified by low pHo, the condition prone to be associated with myocardial ischemia. It turned out that lowering pHo decreased rather than increased the nicorandil-activated KATP in whole-cell currents. Since pHo might lead to change in pHi, and pHi itself would have modifying action on KATP, we proceeded to explore the modulating mechanism by increased H+ concentrations with inside-out patches, where involvement of the second messenger system produced by the drug could be largely excluded.

Effect of internal pH on nicorandil-activated KATP

In the presence of MgATP and ADP in the bath (cytoplasmic face), lowering pHi remarkably increased the Po of the channels, the results consistent with previous reports (Cuevas et al., 1991; Davies, 1990; Fan & Makielski, 1993; Koyano et al., 1993; Vivaudou & Forestier, 1995). This action of low pHi can be interpreted that an intrinsic proton binding site regulates ATP sensitivity for the channel inhibition in KATP (Fan & Makielski, 1993). Evidence of the importance of Mg2+ as a cofactor necessary to keep the channel in operative state in the presence of either ATP or nucleotide diphosphates has been provided as well as its contribution in the enhancement of KCO effect (Findley, 1988; Lederer & Nichols, 1989; Shen et al., 1991; Terzic et al., 1994; Tung & Kurachi, 1991; Vivaudou & Forestier, 1995). We used MgATP combined with small doses of ADP in all our subsequent experiments in order to keep the channel in operative state and minimize run-down. At physiologic pHi 7.2 nicorandil markedly increased the Po of KATP, but when lowering pHi, the Po of nicorandil-activated KATP was significantly decreased. Therefore, it appears that variations in pHi directly affect the interaction between nicorandil and KATP rather than via producing the second messengers such as the production of cyclic GMP (Kojda & Kottenberg, 1999; Kubo et al., 1994; Murphy & Brayden, 1995). This suppressive action on KATP seems to overcome stimulating effect of low pHi.

Modulation of KATP by nitric oxide

In the present study, we demonstrated at the single-channel level that NO donors of different chemical structures increased the Po of KATP at pHi 7.2. Furthermore, removal of NO donors did not abolish the increased activity but the activity was kept increasing, and higher doses of ATP were needed to inhibit the channels than those before the drug treatment, suggesting a reduction of sensitivity to the nucleotide-inhibitory effect. Although the activation of the channels by NO donors was not as large as with nicorandil, the increase in Po was clear and significant. At low pHi, however, the presence of NO donors decreased the Po of the channels and removal of the NO donors did not reverse the phenomenon. Also, with raising pHi from 6.0 to 7.2 in the presence of the NO donors, the increase of Po was evident. Therefore, the effects of the NO donors at either pHi 7.2 or pHi 6.0 were very similar to those observed with nicorandil.

Recently, NO was reported to enhance the KCO-activated KATP current with undefined mechanism (Shinbo & Iijima, 1997). They demonstrated the enhancing action of NO with whole-cell and cell-attached patch recordings in guinea-pig ventricular myocytes at normal pHo and pHi. In their experiments the cyclic GMP pathway and/or metabolic inhibition did not appear to be responsible for NO effects. Their findings were similar to the present results, except they failed to demonstrate the enhancing action of NOR-3 on KATP in inside-out patches. Here, we were able to show a clear activation of the channels by application of two different NO donors to inside-out patches. At present, we could not find any proper reason to explain the discrepancy between the two studies, but a direct action of NO on the modulation of cardiac KATP might be supported. In cultured vascular smooth muscle cells, isosorbide dinitrate and atrial natriuretic factor were proven to modulate the gating of KATP and the cyclic GMP pathway was involved (Kubo et al., 1994). There are, however, several lines of evidence that direct effects of NO on channel modulation; for example, expressed cardiac L-type Ca2+ channels (Hu et al., 1997), calcium-regulated potassium channel in vascular smooth muscle cells (Bolotina et al., 1994) and potassium channels in colonic muscle cells (Koh et al., 1995). Therefore, it may be possible that NO could directly modulate KATP and our findings add new evidence for its role on the modulation of cardiac KATP.

Because of these similarity of actions between the NO donors and nicorandil, the suppression of the nicorandil-activated KATP at low pHi can be attributed to a direct interaction of NO with H+ at ATP-binding inhibitory sites of the channels, where stimulating action of pHi is supposed to interact on this site. This action may be different from the enhancing action of NO and nicorandil on KATP at normal pHi, or some other mechanism to exhibit both stimulating and suppressive actions depending on pH may be involved. This issue is to be explored further. Dual modulations of cardiac KATP have been demonstrated in the actions of pinacidil (Fan et al., 1990), nucleotides diphosphates and Mg2+ (Findley, 1988; Lederer & Nichols, 1989; Tung & Kurachi, 1990; Terzic et al., 1994), and pHi (Cuevas et at., 1991; Fan & Makielski, 1993; Koyano et al., 1993; Fan et al., 1993). The dualistic modulations by these factors develop in variable ways and different mechanisms seem to be involved. For examples, pinacidil exerts voltage-independent activation of the channels and voltage dependent inhibition from inside of the membrane. Nucleotide diphosphates cause channel inhibition without Mg2+ and stimulate the channels in the operative state in the presence of Mg2+. Mg2+ produces channel inactivation and run-down on the one hand, and on the other it promotes the channels into the operative states. Low pHi promotes increased channel open probability but induces decreased single channel current amplitude.

The fact that NO-scavengers were not able to prevent or reverse the actions of NO-donors on the KATP is unclear and needs to be further investigated. In the case of HbO2, the compound itself was shown to affect directly the channel at either normal or lower pHi, and that explains the prominent enhancement of the depressive effect of NO-donors on the channel. Does the KATP have the ability to sense and respond to HbO2 levels? As for carboxy-PTIO, the dose required to abolish the NO effect is much higher than that for HbO2, (Donor: Scavenger ratio=3 : 1) and the release rate of NO is slower, perhaps that might explains why it did not affect NO-H+ interaction respect to KATP.

Possible pathophysiological implications

The openings of KATP play an pivotal role for action potential shortening and are partly responsible for extra-cellular K+ accumulation during early phase of myocardial ischemia and infarction, which may contribute to the development of arrhythmias (Venkatesh et al., 1992; Wilde & Janse, 1994). At the same time, pHi may go down quickly. On the other hand, the openings of KATP may exert the protective action on the second severe ischemic insult after a brief period of ischemia (preconditioning) (Downey & Cohen, 1997; Gross, 1995; Grover, 1994). If the patients taking nicorandil as anti-anginal drug develop ischemic attack, a quick opening of KATP can be anticipated during early ischemic episode and yet, the opening effects are subsequently suppressed due to decreased pHi, which may give a self-limiting factor for the prevention of further shortening of action potential duration and extracellular K+ accumulation. At the same time, KATP as the end effector of cardioprotection is also modulated by NO production (Bolli et al., 1997; Imagawa et al., 1999; Yao and Gross, 1993). Therefore, these interplay and final results in the presence of nicorandil must be evaluated with caution. Acidosis is known to be pro-arrhythmogenic by affecting multiple ionic currents including KATP (Orchard & Cingolani, 1994). Therefore, it might be necessary to further examine the pharmacological profile of these drugs in acidotic conditions.

Conclusions

The present study provides information concerning the effect of H+ at either side of the membrane in nicorandil-activated KATP. We present new evidence of a cyclic GMP-independent modulating effect of NO on KATP during acidosis. These findings may be relevant to the therapeutic action of these drugs, especially during ischemic or hypoxic conditions.

Acknowledgments

We thank Miss K. Totsuka for secretarial services and Mrs K. Yamamoto for excellent technical assistant. We are also grateful for the generous supply of nicorandil by Chugai Pharmaceutical, Co. Ltd. (Tokyo, Japan). Thanks are due to Fujisawa Pharmaceutical Co. Ltd. (Osaka, Japan) for the generous supply of FK409 (NOR3).

Abbreviations

[ATP]i

intracellular ATP concentration

[H+]o

external proton-concentration

[H+]i

internal proton-concentration

KATP

ATP-sensitive K+ channel

KCO

K+ channel opener

pHo

external pH

pHi

internal pH

Po

open-state probability

References

  1. ALLEN D.G., MORRIS P.G., ORCHARD C.H., PIROLO J.S. A nuclear magnetic resonance study of metabolism in the ferret heart during hypoxia and inhibition of glycolisis. J. Physiol. (Lond.) 1985;361:185–204. doi: 10.1113/jphysiol.1985.sp015640. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. BOLLI R., BHATTI Z.A., TANG X.-L., QIU Y., ZHANG Q., GUO Y., JADOON A.K. Evidence that late preconditioning against myocardial stunning in conscious rabbits is triggered by the generation of nitric oxide. Circ. Res. 1997;81:42–52. doi: 10.1161/01.res.81.1.42. [DOI] [PubMed] [Google Scholar]
  3. BOLOTINA V.M., NAJIBI S., PALACINO J.J., PAGANO P.J., COHEN R.A. Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature. 1994;368:850–853. doi: 10.1038/368850a0. [DOI] [PubMed] [Google Scholar]
  4. CUEVAS J., BASSET A.L., CAMERON J.S., FURUKAWA T., MYERBURG R.J., KIMURA S. Effect of H+ on ATP-regulated K+ channels in feline ventricular myocytes. Am. J. Physiol. 1991;261:H755–H761. doi: 10.1152/ajpheart.1991.261.3.H755. [DOI] [PubMed] [Google Scholar]
  5. DAVIES N.W. Modulation of ATP-sensitive channels in skeletal muscle by intracellular protons. Nature. 1990;343:375–377. doi: 10.1038/343375a0. [DOI] [PubMed] [Google Scholar]
  6. DOWNEY J.M., COHEN M.V. Signal transduction in ischemic preconditioning. Adv. Exp. Med. Biol. 1997;430:39–55. doi: 10.1007/978-1-4615-5959-7_4. [DOI] [PubMed] [Google Scholar]
  7. FAN Z., MAKIELSKI J.C. Intracellular H+ and Ca2+ Modulation of Trypsin-Modified ATP-sensitive K+ channels in Rabbit Ventricular Myocytes. Circ. Res. 1993;72:715–722. doi: 10.1161/01.res.72.3.715. [DOI] [PubMed] [Google Scholar]
  8. FAN Z., FURUKAWA T., SAWANOBORI T., MAKIELSKI J.C., HIRAOKA M. Cytoplasmic acidosis induces multiple conductance states in ATP-sensitive potassium channels of cardiac myocytes. J. Memb. Biol. 1993;136:169–179. doi: 10.1007/BF02505761. [DOI] [PubMed] [Google Scholar]
  9. FAN Z., NAKAYAMA K., HIRAOKA M. Multiple action of pinacidil on adenosine triphosphate-sensitive potassium channels in guinea-pig ventricular myocytes. J. Physiol. 1990;430:273–295. doi: 10.1113/jphysiol.1990.sp018291. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. FINDLAY I. Effect of ADP upon the ATP-sensitive K+ channel in rat ventricular myocytes. J. Memb. Biol. 1988;101:83–92. doi: 10.1007/BF01872823. [DOI] [PubMed] [Google Scholar]
  11. FRAMPTON J., BUCKLEY M.M., FILTON A. Nicorandil. A review of its pharmacology and therapeutic efficacy in angina pectoris. Drugs. 1992;44:625–655. doi: 10.2165/00003495-199244040-00008. [DOI] [PubMed] [Google Scholar]
  12. GOLDSCHIMIDT M., LANDZBERG B.R., FRISHMAN W.H. Nicorandil: a potassium channel opening drug for the treatment of ischemic heart disease (Review) J. Clin Pharmacol. 1996;36:559–572. doi: 10.1002/j.1552-4604.1996.tb04219.x. [DOI] [PubMed] [Google Scholar]
  13. GROSS G.J. ATP-sensitive potassium channels and myocardial preconditioning. Basic Res. Cardiol. 1995;90:85–88. doi: 10.1007/BF00789438. [DOI] [PubMed] [Google Scholar]
  14. GROVER G.J. Protective effects of ATP-sensitive potassium channel openers in experimental myocardial ischemia. J. Cardiovasc. Pharmacol. 1994;24 suppl. 4:S18–S27. [PubMed] [Google Scholar]
  15. HAMILL O.P., MARTY A., NEHER E., SACKMAN B., SIGWORTH F. Improved patch-clamp techniques for high-resolution current recordings from cells and cell-free membrane patches. Pluggers Arch. 1981;351:85–100. doi: 10.1007/BF00656997. [DOI] [PubMed] [Google Scholar]
  16. HIRANO Y., HIRAOKA M. Barium-induced automatic activity in isolated ventricular myocytes from guinea-pig hearts. J. Physiol. 1988;395:455–472. doi: 10.1113/jphysiol.1988.sp016929. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. HIRAOKA M., FAN Z. Activation of ATP-sensitive outward K+ current by nicorandil (2-nicotinamidoethyl nitrate) in isolated ventricular myocytes. J. Pharmacol. Exp. Ther. 1989;250:278–285. [PubMed] [Google Scholar]
  18. HU H., CHIAMVIMONVANT N., YAMAGISHI T., MARBAN E. Direct inhibition of expressed cardiac L-type Ca2+ channels by S-nitrosothiol nitric oxide donors. Circ. Res. 1997;81:742–752. doi: 10.1161/01.res.81.5.742. [DOI] [PubMed] [Google Scholar]
  19. IMAGAWA J.-I., YELLON D.M., BAXTER G.F. Pharmacological evidence that inducible nitric oxide synthase is a mediator of delayed preconditioning. Br. J. Pharmacol. 1999;126:701–708. doi: 10.1038/sj.bjp.0702368. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. JAHANGIR A., TERZIC A., KURACHI Y. Intracellular acidification and ADP enhance nicorandil induction of ATP sensitive potassium channel current in cardiomyocytes. Cardiovasc. Res. 1994;28:831–835. doi: 10.1093/cvr/28.6.831. [DOI] [PubMed] [Google Scholar]
  21. KOH S.D., CAMPBELL J.D., CARL A., SANDERS K.M. Nitric oxide activates multiple potassium channels in canine colonic smooth muscle. J. Physiol. 1995;489:735–743. doi: 10.1113/jphysiol.1995.sp021087. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. KOJDA G., KOTTENBERG K. Regulation of basal myocardial function by NO. Cardiovasc. Res. 1999;41:514–523. doi: 10.1016/s0008-6363(98)00314-9. [DOI] [PubMed] [Google Scholar]
  23. KOYANO T., KAKEI M., NAKASHIMA H., YOSHINAGA M., MATSUOKA T., TANAKA H. ATP-regulated K+ channels are modulated by intracellular H+ in guinea pig ventricular cells. J. Physiol. 1993;463:747–766. doi: 10.1113/jphysiol.1993.sp019620. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. KRUMENACKER M., ROLAND E. Clinical profile of nicorandil: an overview of its hemodynamic properties and therapeutic efficacy. J. Cardiovasc. Pharmacol. 1992;20:S93–S102. [PubMed] [Google Scholar]
  25. KUBO M., NAKAYA Y., MATSUOKA S., SAITO K., KURODA Y. Atrial natriuretic factor and isosorbide dinitrate modulate the gating of ATP-sensitive K+ channels in cultured vascular smooth muscle cells. Circ. Res. 1994;74:471–476. doi: 10.1161/01.res.74.3.471. [DOI] [PubMed] [Google Scholar]
  26. KWOK W.M., KASS R.S. Inhibition of pinacidil induced IK(ATP) in heart by changes in extracellular pH. Cardiovasc. Res. 1994;28:836–840. doi: 10.1093/cvr/28.6.836. [DOI] [PubMed] [Google Scholar]
  27. LEDERER W.J., NICHOLS C.G. Nucleotide modulation of the activity of rat heart ATP-sensitive K+ channels in isolated membrane patches. J. Physiol. 1989;419:193–211. doi: 10.1113/jphysiol.1989.sp017869. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. MATSUBARA T., MINATOGUCHI S., MATSU H., HAYAKAWA K., SEGAWA T., MATSUNO Y., WATANABE S., ARAI M., UNO Y., KAWASAKI M., NODA T., TAKEMURA G., NISHIGAKI K., FUJIWARA H. Three minute, but not one minute, ischemia and nicorandil have a preconditioning effect in patients with coronary artery disease. J. Am. Coll. Cardiol. 2000;35:345–351. doi: 10.1016/s0735-1097(99)00539-2. [DOI] [PubMed] [Google Scholar]
  29. MURPHY M.E., BRAYDEN J.E. Nitric oxide hyperpolarizes rabbit mesenteric arteries via ATP-sensitive potassium channels. J. Physiol. (Lond). 1995;486:47–58. doi: 10.1113/jphysiol.1995.sp020789. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. NAKAYAMA K., FAN Z., MARUMO F., SAWANOBORI T., HIRAOKA M. Action of nicorandil on ATP-sensitive K+ channel in guinea-pig ventricular myocytes. Br. J. Pharmacol. 1991;103:1641–1648. doi: 10.1111/j.1476-5381.1991.tb09841.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. ORCHARD C.H., CINGOLANI H.E. Acidosis and arrhythmias in cardiac muscle (Review) Cardiovasc. Res. 1994;28:1312–1319. doi: 10.1093/cvr/28.9.1312. [DOI] [PubMed] [Google Scholar]
  32. PATEL D.J., PURCELL H.J., FOX K.M. Cardioprotection by opening of the K (ATP) channel in unstable angina. Is this a clinical manifestation of myocardial preconditioning? Results of a randomized study with nicorandil. CESAR 2 investigation. Clinical European studies in angina and revascularization. Eur. Heart. J. 1999;20:51–57. doi: 10.1053/euhj.1998.1354. [DOI] [PubMed] [Google Scholar]
  33. SHEN W.K., TUNG R.T., MACHULDA M.M., KURACHI Y. Essential role of nucleotide diphosphates in nicorandil-mediated activation of cardiac ATP-sensitive K+ channels. Circ. Res. 1991;69:1152–1158. doi: 10.1161/01.res.69.4.1152. [DOI] [PubMed] [Google Scholar]
  34. SHINBO A., IIJIMA T. Potentiation by nitric oxide of the ATP-sensitive K+ current induced by K+ channels openers in guinea-pig ventricular cells. Br. J. Pharmacol. 1997;120:1568–1574. doi: 10.1038/sj.bjp.0701069. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. TAIRA N. Similarity and dissimilarity in the mode and mechanism of action between nicorandil and classical nitrates: An overview. J. Cardiovasc. Pharmacol. 1987;10 suppl. 8:S1–S9. [PubMed] [Google Scholar]
  36. TAKANO M., NOMA A. Selective modulation of the ATP-sensitive K+ channel by nicorandil in guinea-pig cardiac cell membrane. Naunyn-Schmideberg's Arch. Pharmacol. 1990;342:592–597. doi: 10.1007/BF00169050. [DOI] [PubMed] [Google Scholar]
  37. TERZIC A., FINDLAY I., HOSOYA Y., KURACHI Y. Dualistic behavior of ATP-sensitive K+ channels toward intracellular nucleotide diphosphates. Neurone. 1994;12:1049–1058. doi: 10.1016/0896-6273(94)90313-1. [DOI] [PubMed] [Google Scholar]
  38. TUNG R.T., KURACHI Y. On the mechanism of nucleotide diphosphate activation of the cardiac ATP-sensitive K+ channel in ventricular cell of guinea-pig. J. Physiol. (Lond). 1991;437:239–256. doi: 10.1113/jphysiol.1991.sp018593. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. VENKATESH N., STUART J.S., LAMP S.T., ALEXANDER L.D., WEISS J.N. Activation of ATP-sensitive K+ channels by cromakalim. Effects on cellular K+ loss and cardiac function in ischemic and reperfused mammalian ventricle. Circ. Res. 1992;71:1324–1333. doi: 10.1161/01.res.71.6.1324. [DOI] [PubMed] [Google Scholar]
  40. VIVAUDOU M., FORESTIER C. Modification by protons of frog skeletal muscle KATP channels: effects on ion conduction and nucleotide inhibition. J. Physiol. (Lond.) 1995;486:629–645. doi: 10.1113/jphysiol.1995.sp020840. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. WILDE A.A.M., JANSE M.J. Electrophysiological effects of ATP-sensitive poptassium channel modulation: implications for arrhythmogenesis. Cardiovasc. Res. 1994;28:16–24. doi: 10.1093/cvr/28.1.16. [DOI] [PubMed] [Google Scholar]
  42. YAO Z., GROSS G.J. Role of nitric oxide, muscarinic receptors, and the ATP-sensitive K+ channel in mediating the effects of acetylcholine to mimic preconditioning dogs. Circ. Res. 1993;73:1193–1201. doi: 10.1161/01.res.73.6.1193. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES